Pazopanib
From IDWiki
- Tyrosine kinase inhibitor
- Inhibits multiple targets, including vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), c-KIT, and FGFR
- Indicated for renal cell carcinoma and soft tissue sarcoma
